Registry 17-009: Multi-Institutional Study Examining Patients With HCC Undergoing Liver Transplantation

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06018857

Enrollment

1000

Registered

2023-08-31

Start date

2017-05-11

Completion date

2028-12-01

Last updated

2026-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular Carcinoma

Brief summary

This is a registry study examining patients with HCC undergoing liver transplantation including outcomes and predictors of recurrence

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Adult patients (age\>18 years) undergoing Liver transplant for hepatocellular carcinoma

Exclusion criteria

* Patients under 18 years old * Patients who do not have hepatocellular carcinoma * patients who have hepatocellular carcinoma but do not undergo liver transplantation

Design outcomes

Primary

Measure	Time frame
Recurrence Free Survival	From date of surgery to date of identified cancer recurrence through either clinical judgement or scans. This is assessed up to 10 years after the surgery.
Overall Survival	From date of surgery to date of death, up to 10 years after the surgery.

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORFederico Aucejo, MD

The Cleveland Clinic

Outcome results